Stocktoria
CytomX Therapeutics, Inc. CTMX
CytomX Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| Point72 Asset Management, L.P. | 7,811,033 | $29.3M | 4.59% |
| TWO SIGMA INVESTMENTS, LP | 4,132,643 | $15.5M | 2.43% |
| CITADEL ADVISORS LLC | 3,330,109 | $12.5M | 1.96% |
| MILLENNIUM MANAGEMENT LLC | 1,685,830 | $6.3M | 0.99% |
| BlackRock Finance, Inc. | 1,139,029 | $1.4M | 0.67% |
| AQR CAPITAL MANAGEMENT LLC | 42,014 | $157,553 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.